Bilcare, a company in the Healthcare Research, Analytics & Technology industry, reported revenue of ₹248 crore and net profit of ₹1.07 crore for the September 2026 quarter.
Bilcare (NSE: BI-BE) closed at ₹76.84 on 20 Nov 2026. Its market capitalisation is ₹181 crore and it trades at 5.0 times earnings.
Incorporated in 1987, Bilcare Ltd. is engaged in the business of Pharmaceutical Packaging, Global Clinical Services, R&D services and Anti Counterfeit Technology (nCid).
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.